These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36720841)

  • 1. Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoids.
    Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Prinzi N; Pusceddu S; Missiato L; Colantuono M; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
    Histopathology; 2023 May; 82(6):870-884. PubMed ID: 36720841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
    Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Fabbri A; Prinzi N; Garzone G; Filugelli M; Pardo C; Mietta A; Pusceddu S; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
    Histopathology; 2023 Jan; 82(2):324-339. PubMed ID: 36239545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
    Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
    Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors: Ki-67 Index Predicts Progression-free Survival and Atypical Histology.
    Naso JR; Jenkins SM; Roden AC; Yi ES; Lo YC; Bois MC; Maleszewski JJ; Aubry MC; Boland JM
    Am J Surg Pathol; 2024 Jun; 48(6):742-750. PubMed ID: 38584496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids.
    Swarts DR; Rudelius M; Claessen SM; Cleutjens JP; Seidl S; Volante M; Ramaekers FC; Speel EJ
    Histopathology; 2017 Feb; 70(3):412-422. PubMed ID: 27701763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 and OTP are strong prognostic markers for pulmonary carcinoids.
    Swarts DR; Henfling ME; Van Neste L; van Suylen RJ; Dingemans AM; Dinjens WN; Haesevoets A; Rudelius M; Thunnissen E; Volante M; Van Criekinge W; van Engeland M; Ramaekers FC; Speel EJ
    Clin Cancer Res; 2013 Apr; 19(8):2197-207. PubMed ID: 23444222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
    Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
    Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation.
    Moonen L; Mangiante L; Leunissen DJG; Lap LMV; Gabriel A; Hillen LM; Roemen GM; Koch A; van Engeland M; Dingemans AC; Foll M; Alcala N; Fernandez-Cuesta L; Derks JL; Speel EM
    Int J Cancer; 2022 Jun; 150(12):1987-1997. PubMed ID: 35076935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of cyclin A2 and B1 expression in lung carcinoids.
    Brcic L; Heidinger M; Sever AZ; Zacharias M; Jakopovic M; Fediuk M; Maier A; Quehenberger F; Seiwerth S; Popper H
    Pathology; 2019 Aug; 51(5):481-486. PubMed ID: 31230818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
    Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
    Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive pathological and clinical features of lung carcinoids with high proliferation index.
    Marchiò C; Gatti G; Massa F; Bertero L; Filosso P; Pelosi G; Cassoni P; Volante M; Papotti M
    Virchows Arch; 2017 Dec; 471(6):713-720. PubMed ID: 28631159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence.
    Marchevsky AM; Hendifar A; Walts AE
    Mod Pathol; 2018 Oct; 31(10):1523-1531. PubMed ID: 29802361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
    Milione M; Maisonneuve P; Grillo F; Mangogna A; Centonze G; Prinzi N; Pusceddu S; Garzone G; Cattaneo L; Busico A; Bossi P; Spaggiari P; Pellegrinelli A; Del Gobbo A; Ferrero S; Kankava K; Pruneri G; Rolli L; Roca E; Bercich L; Tironi A; Benvenuti MR; Gallazzi MS; Romano R; Berruti A; Pastorino U; Capella C
    Neuroendocrinology; 2021; 111(5):475-489. PubMed ID: 32365350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
    Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver variability for the WHO classification of pulmonary carcinoids.
    Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
    Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic score for survival with pulmonary carcinoids: the importance of associating clinical with pathological characteristics.
    Chiappetta M; Sperduti I; Ciavarella LP; Leuzzi G; Bria E; Mucilli F; Lococo F; Filosso P; Ratto G; Spaggiari L; Facciolo F; Margaritora S
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):315-323. PubMed ID: 32747930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.
    Cusumano G; Fournel L; Strano S; Damotte D; Charpentier MC; Galia A; Terminella A; Nicolosi M; Regnard JF; Alifano M
    Lung; 2017 Dec; 195(6):789-798. PubMed ID: 29022070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
    Rekhtman N; Desmeules P; Litvak AM; Pietanza MC; Santos-Zabala ML; Ni A; Montecalvo J; Chang JC; Beras A; Preeshagul IR; Sabari JK; Rudin CM; Ladanyi M; Klimstra DS; Travis WD; Lai WC
    Mod Pathol; 2019 Jul; 32(8):1106-1122. PubMed ID: 30923345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.